Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Treatment Period	STARTED	Placebo	94
Treatment Period	STARTED	Elagolix	95
Treatment Period	STARTED	Elagolix + E2/NETA	189
Treatment Period	COMPLETED	Placebo	72
Treatment Period	COMPLETED	Elagolix	69
Treatment Period	COMPLETED	Elagolix + E2/NETA	148
Treatment Period	NOT COMPLETED	Placebo	22
Treatment Period	NOT COMPLETED	Elagolix	26
Treatment Period	NOT COMPLETED	Elagolix + E2/NETA	41
Post-Treatment Follow-Up Period	STARTED	Placebo	14
Post-Treatment Follow-Up Period	STARTED	Elagolix	25
Post-Treatment Follow-Up Period	STARTED	Elagolix + E2/NETA	59
Post-Treatment Follow-Up Period	COMPLETED	Placebo	9
Post-Treatment Follow-Up Period	COMPLETED	Elagolix	18
Post-Treatment Follow-Up Period	COMPLETED	Elagolix + E2/NETA	42
Post-Treatment Follow-Up Period	NOT COMPLETED	Placebo	5
Post-Treatment Follow-Up Period	NOT COMPLETED	Elagolix	7
Post-Treatment Follow-Up Period	NOT COMPLETED	Elagolix + E2/NETA	17

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02691494/flow